P

Inventor

BIENIARZ CHRISTOPHER

US76 patents
⚠️ This page may combine multiple inventors who share the name “BIENIARZ CHRISTOPHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT LAB

22 patents
US5599932AFeb 4, 1997

Intercalators having affinity for DNA and methods of use

ABBOTT LAB57 citations95
US5582984ADec 10, 1996

Methods of use of phenanthridium DNA intercalators for fluorescence detection

ABBOTT LAB56 citations95
US6100434AAug 8, 2000

Method for synthesizing sevoflurane and an intermediate thereof

ABBOTT LAB53 citations94
US5994143ANov 30, 1999

Polymeric fluorophores enhanced by moieties providing a hydrophobic and conformationally restrictive microenvironment

ABBOTT LAB56 citations94
US5002883AMar 26, 1991

Covalent attachment of antibodies and antigens to solid phases using extended length heterobifunctional coupling agents

ABBOTT LAB70 citations93
US6015902AJan 18, 2000

Intercalators having affinity for DNA and methods of use

ABBOTT LAB45 citations92
US4978613ADec 18, 1990

Beta-lactamase assay employing chromogenic precipitating substrates

ABBOTT LAB28 citations92
US5990176ANov 23, 1999

Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

ABBOTT LAB24 citations91
US5053520AOct 1, 1991

Heterobifunctional maleimido containing coupling agents

ABBOTT LAB48 citations91
US4994385AFeb 19, 1991

Heterobifunctional coupling agents

ABBOTT LAB36 citations91
US6677492B2Jan 13, 2004

Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

ABBOTT LAB13 citations90
US5661040AAug 26, 1997

Fluorescent polymer labeled conjugates and intermediates

ABBOTT LAB48 citations89
US5191066AMar 2, 1993

Site-specific conjugation of immunoglobulins and detectable labels

ABBOTT LAB45 citations88
US6057429AMay 2, 2000

Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents

ABBOTT LAB14 citations81
US5789219AAug 4, 1998

Phosphatase activated crosslinking conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents

ABBOTT LAB16 citations81
US5736624AApr 7, 1998

Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents

ABBOTT LAB14 citations81
US6444859B2Sep 3, 2002

Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

ABBOTT LAB12 citations80
US6288127B1Sep 11, 2001

Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

ABBOTT LAB13 citations80
US5063109ANov 5, 1991

Covalent attachment of antibodies and antigens to solid phases using extended length heterobifunctional coupling agents

ABBOTT LAB19 citations76
US5272260ADec 21, 1993

Reagents and methods for the determination of glycohydrolytic enzymes

ABBOTT LAB12 citations74
US6160153ADec 12, 2000

Phosphatase activated crosslinking conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating

ABBOTT LAB10 citations73
US5516647AMay 14, 1996

Compounds useful as alkaline phosphatase inhibitors and therapeutic agents

ABBOTT LAB10 citations71

VENTANA MED SYST INC

18 patents
US7695929B2Apr 13, 2010

Haptens, hapten conjugates, compositions thereof and method for their preparation and use

VENTANA MED SYST INC68 citations97
US7985557B2Jul 26, 2011

Polymeric carriers for immunohistochemistry and in situ hybridization

VENTANA MED SYST INC31 citations94
US7642064B2Jan 5, 2010

Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest

VENTANA MED SYST INC23 citations92
US9017954B2Apr 28, 2015

Polymeric carriers for immunohistochemistry and in situ hybridization

VENTANA MED SYST INC16 citations91
US7632652B2Dec 15, 2009

Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences

VENTANA MED SYST INC25 citations91
US7541455B2Jun 2, 2009

Microwave mediated synthesis of nucleic acid probes

VENTANA MED SYST INC14 citations84
US7682789B2Mar 23, 2010

Method for quantifying biomolecules conjugated to a nanoparticle

VENTANA MED SYST INC16 citations83
US10168336B2Jan 1, 2019

Quinone methide analog signal amplification

VENTANA MED SYST INC10 citations82
US9575067B2Feb 21, 2017

Polymeric carriers for immunohistochemistry and in situ hybridization

VENTANA MED SYST INC5 citations82
US10620217B2Apr 14, 2020

Proximity assays using chemical ligation and hapten transfer

VENTANA MED SYST INC3 citations73
US12092643B2Sep 17, 2024

Detecting targets using mass tags and mass spectrometry

VENTANA MED SYST INC1 citations72
US10883999B2Jan 5, 2021

Detecting targets using mass tags and mass spectrometry

VENTANA MED SYST INC2 citations72
US10078083B2Sep 18, 2018

Detecting targets using mass tags and mass spectrometry

VENTANA MED SYST INC2 citations72
US11780863B2Oct 10, 2023

Quinone methide analog signal amplification

VENTANA MED SYST INC3 citations71
US11740233B2Aug 29, 2023

Antibody-nanoparticle conjugates and methods for making and using such conjugates

VENTANA MED SYST INC1 citations71
US11365210B2Jun 21, 2022

Quinone methide analog signal amplification

VENTANA MED SYST INC1 citations71
US10775281B2Sep 15, 2020

Polymer stabilization of chromogen solutions

VENTANA MED SYST INC1 citations71
US9618429B2Apr 11, 2017

Polymer stabilization of chromogen solutions

VENTANA MED SYST INC2 citations71

KOSMEDER JEROME W

4 patents

BIENIARZ CHRISTOPHER

2 patents

ASHWORTH-SHARPE JULIA

1 patent

GNIEWEK RICHARD

1 patent

KRAM BRIAN H

1 patent

HONG RUI

1 patent

Showing the top 50 of 76 patents by PatentIndex Score.